How fast does a BCC grow if left untreated? 

Basal cell carcinoma is widely recognised in the United Kingdom as a slow-growing form of non-melanoma skin cancer. Unlike more aggressive malignancies that can spread rapidly to distant organs, a basal cell carcinoma typically expands locally over a period of many months or even years. However, the term slow-growing should not be equated with harmless. If left untreated, these lesions act as locally invasive tumours that can cause significant destruction to the surrounding skin, cartilage, and bone. Understanding the typical progression of a basal cell carcinoma is essential for identifying the point at which medical intervention is required to ensure a successful clinical outcome. 

What We’ll Discuss in This Article 

• The average growth rate of a typical nodular basal cell carcinoma 

• Variations in speed between different subtypes of the disease 

• The biological mechanism of local tissue invasion and destruction 

• Why a slow growth rate often leads to a delay in diagnosis 

• The impact of the tumour’s location on the urgency of treatment 

• Long-term consequences of neglecting a slow-growing skin cancer 

The average growth rate of a typical nodular lesion 

In most cases, a nodular basal cell carcinoma grows at a rate of only a few millimetres per year. This extremely gradual expansion is often why patients do not notice any significant change from one month to the next. A lesion may start as a tiny, pearly bump and take several years to reach a diameter of one centimetre. This predictable and steady growth pattern is a hallmark of the disease and is a key reason why it is rarely considered a medical emergency in its early stages. 

Despite this slow pace, the tumour is constantly active beneath the surface of the skin. The National Health Service explains that while basal cell carcinoma is slow-growing and almost never spreads to other parts of the body, it can cause significant local damage if it is not treated early. Because the growth is often horizontal across the skin as well as vertical into the deeper layers, the visible part of the bump may only represent a portion of the total tumour mass. 

Variations in speed between different BCC subtypes 

While the average growth is slow, the specific subtype of basal cell carcinoma can influence how quickly it progresses. Superficial basal cell carcinoma, which appears as a flat red patch, often expands horizontally very slowly and can remain relatively unchanged for years. In contrast, more aggressive subtypes such as infiltrative or morphoeic basal cell carcinoma can grow more quickly and unpredictably. These types often have finger-like projections that extend into the surrounding healthy tissue, making them harder to define and remove. 

Morphoeic basal cell carcinoma, in particular, can look like a firm scar and may grow silently beneath the skin for a long time before it becomes obvious on the surface. These infiltrative types are often associated with a higher risk of recurrence because their true margins are difficult to identify during standard surgery. If you notice a skin lesion that seems to be changing shape or size more rapidly than a few millimetres a year, it may indicate a more aggressive subtype that requires a prioritised clinical assessment. 

The biological mechanism of local tissue invasion 

The primary danger of an untreated basal cell carcinoma is its ability to invade and destroy the healthy tissues in its path. As the tumour grows, it releases enzymes that break down the structural proteins in the skin, such as collagen. This allows the cancer cells to push through the layers of the dermis and reach deeper structures. If the lesion is located on the face, it can eventually grow into the underlying cartilage of the nose or ears, or even the bone of the eye socket or jaw. 

This destructive process is why a basal cell carcinoma is sometimes referred to as a rodent ulcer. NICE clinical guidelines state that the goal of treatment is to remove the tumour entirely while it is still small to prevent the need for complex reconstructive surgery following the destruction of facial features. Once the tumour reaches deeper tissues, the surgery required to clear it becomes much more extensive, potentially involving skin grafts or flaps to repair the resulting defect. 

Why a slow growth rate leads to diagnostic delay 

The deceptive nature of a slow-growing cancer is that it does not create a sense of urgency for the patient. Many people in the UK wait an average of twelve to eighteen months from first noticing a shiny bump to seeking medical advice. Because the lesion does not cause pain, itching, or rapid change, it is often dismissed as a harmless age spot or a persistent blemish. This delay allows the tumour to establish a deeper root system within the skin, making the eventual treatment more involved. 

Furthermore, a basal cell carcinoma may occasionally seem to shrink or heal, especially if a central ulcer scabs over. This intermittent healing can give a false sense of security, leading the patient to believe the issue has resolved itself. However, the cancer cells remain at the base of the lesion and will inevitably continue their slow expansion. It is a vital clinical rule that any skin spot that has not completely disappeared within four weeks should be examined by a healthcare professional, regardless of how slowly it appears to be growing. 

Impact of location on treatment urgency 

The location of a basal cell carcinoma significantly influences how a doctor views the urgency of its growth. A lesion on the trunk or limbs that is growing by two millimetres a year may be less concerning than one of the same size on the eyelid, the bridge of the nose, or the lip. In these high-risk areas, even a few millimetres of growth can affect the function of the feature or make a successful surgical repair much more difficult to achieve. 

On the face, there is very little tissue between the skin and the underlying vital structures. A tumour on the eyelid can quickly grow to involve the conjunctiva or the tear ducts, while one on the ear can reach the cartilage within a relatively short period. For this reason, basal cell carcinomas in these locations are often treated with a high degree of precision, such as Mohs micrographic surgery, to ensure the smallest possible amount of healthy tissue is removed while still achieving a complete cure. 

Conclusion 

Basal cell carcinoma typically grows very slowly, often only expanding by a few millimetres each year. However, if left untreated, it will continue to invade the local skin and can eventually destroy underlying cartilage and bone. Because this growth is painless and gradual, it is often ignored, which increases the complexity of the eventual treatment. Early intervention while the lesion is small is the most effective way to ensure a complete cure and minimal scarring. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.